Regenxbio Inc Call to Discuss Eye Care Collaboration with Abbvie Inc Transcript
Good morning and welcome to the AbbVie and REGENXBIO announce eye care collaboration conference call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the call over to Mr. Patrick Christmas, Chief Legal Officer of REGENXBIO. You may begin.
Good morning and thank you for joining us today. Speaking on behalf of REGENXBIO this morning is Ken Mills, REGENXBIO's President and Chief Executive Officer; joined by Vit Vasista, our Chief Financial Officer; Dr. Steve Pakola, our Chief Medical Officer; Curran Simpson, our Chief Operations and Technology Officer; and Ram Palanki, our Senior Vice President of Commercial Strategy and Operations, who will each be available for questions and answers.
Earlier this morning, REGENXBIO issued a press release announcing an eye care collaboration with AbbVie. This press release is available on our website at www.regenxbio.com<
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |